Roles of Cells from the Arterial Vessel Wall in Atherosclerosis

Mediators of Inflammation

Volumn 2017, Issue , 2017, Pages

  Wang, Di ^a   Wang, Zhiyan ^a   Zhang, Lili ^a   Wang, Yi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; INTERFERON; TUMOR NECROSIS FACTOR;

ADIPOCYTE; ADVENTITIA; ARTERY MEDIA; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HUMAN; INTIMA; PERIVASCULAR ADIPOSE TISSUE; REVIEW; SMOOTH MUSCLE CELL; ADIPOSE TISSUE; ANIMAL; ARTERY; CELL MOTION; CYTOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADIPOSE TISSUE; ANIMALS; ARTERIES; ATHEROSCLEROSIS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; HUMANS; MYOCYTES, SMOOTH MUSCLE;

EID: 85021624187     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2017/8135934     Document Type: Review

References (58)

1. A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. Murray, "Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data," Lancet, vol. 367, no. 9524, pp. 1747-1757, 2006.
2. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., "Heart disease and stroke statistics-2016 update: a report from the American Heart Association," Circulation, vol. 133, no. 4, pp. e38-360, 2016.
3. R. Ross, "The pathogenesis of atherosclerosis: a perspective for the 1990s," Nature, vol. 362, no. 6423, pp. 801-809, 1993.
4. Y. Nakashima, H. Fujii, S. Sumiyoshi, T. N. Wight, and K. Sueishi, "Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 5, pp. 1159-1165, 2007.
5. I. Tabas, K. J. Williams, and J. Boren, "Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications," Circulation, vol. 116, no. 16, pp. 1832-1844, 2007.
6. M. L. Ballinger, N. Osman, K. Hashimura et al., "Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo," Journal of Cellular and Molecular Medicine, vol. 14, no. 6B, pp. 1408-1418, 2010.
7. R. Ross, "Atherosclerosis - an inflammatory disease," The New England Journal of Medicine, vol. 340, no. 2, pp. 115-126, 1999.
8. P. Libby, "Inflammation in atherosclerosis," Nature, vol. 420, no. 6917, pp. 868-874, 2002.
9. C. Lahoute, O. Herbin, Z. Mallat, and A. Tedgui, "Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets," Nature Reviews. Cardiology, vol. 8, no. 6, pp. 348-358, 2011.
10. U. Sadat, F. A. Jaffer, M. A. van Zandvoort, S. J. Nicholls, D. Ribatti, and J. H. Gillard, "Inflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets," Circulation, vol. 130, no. 9, pp. 786-794, 2014.
11. K. Maiellaro and W. R. Taylor, "The role of the adventitia in vascular inflammation," Cardiovascular Research, vol. 75, no. 4, pp. 640-648, 2007.
12. S. N. Verhagen and F. L. Visseren, "Perivascular adipose tissue as a cause of atherosclerosis," Atherosclerosis, vol. 214, no. 1, pp. 3-10, 2011.
13. R. Ross and J. A. Glomset, "Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis," Science, vol. 180, no. 4093, pp. 1332-1339, 1973.
14. J. Zhou, Y. S. Li, and S. Chien, "Shear stress-initiated signaling and its regulation of endothelial function," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 10, pp. 2191-2198, 2014.
15. P. R. Moreno, K. R. Purushothaman, E. Zias, J. Sanz, and V. Fuster, "Neovascularization in human atherosclerosis," Circulation, vol. 113, no. 18, pp. 2245-2252, 2006.
16. T. Szasz and R. C. Webb, "Perivascular adipose tissue: more than just structural support," Clinical Science (London, England), vol. 122, no. 1, pp. 11-12, 2012.
17. B. G. Schwartz, C. Economides, G. S. Mayeda, S. Burstein, and R. A. Kloner, "The endothelial cell in health and disease: its function, dysfunction, measurement and therapy," International Journal of Impotence Research, vol. 22, no. 2, pp. 77-90, 2010.
18. X. Hu, X. Xu, G. Zhu et al., "Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine," Circulation, vol. 120, no. 22, pp. 2222-2229, 2009.
19. N. M. Hamburg, M. J. Keyes, M. G. Larson et al., "Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study," Circulation, vol. 117, no. 19, pp. 2467-2474, 2008.
20. K. H. Park and W. J. Park, "Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches," Journal of Korean Medical Science, vol. 30, no. 9, pp. 1213-1225, 2015.
21. M. Barton, "Prevention and endothelial therapy of coronary artery disease," Current Opinion in Pharmacology, vol. 13, no. 2, pp. 226-241, 2013.
22. A. Zernecke and C. Weber, "Chemokines in the vascular inflammatory response of atherosclerosis," Cardiovascular Research, vol. 86, no. 2, pp. 192-201, 2010.
23. N. D. Brunetti, G. Salvemini, A. Cuculo et al., "Coronary artery ectasia is related to coronary slowflowand inflammatory activation," Atherosclerosis, vol. 233, no. 2, pp. 636-640, 2014.
24. G. Luc, J. M. Bard, I. Juhan-Vague et al., "C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME study," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 7, pp. 1255-1261, 2003.
25. J. E. Van Loon, M. Kavousi, F. W. Leebeek et al., "von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population," Journal of Thrombosis and Haemostasis, vol. 10, no. 7, pp. 1262-1269, 2012.
26. G. K. Owens, "Regulation of differentiation of vascular smooth muscle cells," Physiological Reviews, vol. 75, no. 3, pp. 487-517, 1995.
27. A. Margariti, L. Zeng, and Q. Xu, "Stem cells, vascular smooth muscle cells and atherosclerosis," Histology and Histopathology, vol. 21, no. 9, pp. 979-985, 2006.
28. X. Z. Ruan, J. F. Moorhead, J. L. Tao et al., "Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 5, pp. 1150-5, 2006.
29. Y. Ishikawa, M. Kimura-Matsumoto, M. Murakami et al., "Distribution of smooth muscle cells and macrophages expressing scavenger receptor BI/II in atherosclerosis," Journal of Atherosclerosis and Thrombosis, vol. 16, no. 6, pp. 829-839, 2009.
30. J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby, "Nitric oxide and the proliferation of vascular smooth muscle cells," Cardiovascular Research, vol. 43, no. 3, pp. 580-594, 1999.
31. J. Hou, X. Xue, and J. Li, "Vasostatin-2 inhibits cell proliferation and adhesion in vascular smooth muscle cells, which are associated with the progression of atherosclerosis," Biochemical and Biophysical Research Communications, vol. 469, no. 4, pp. 948-953, 2016.
32. Y. Lang, D. Chen, D. Li et al., "Luteolin inhibited hydrogen peroxide-induced vascular smooth muscle cells proliferation and migration by suppressing the Src and Akt signalling pathways," The Journal of Pharmacy and Pharmacology, vol. 64, no. 4, pp. 597-603, 2012.
33. S. M. Schwartz, R. Virmani, and M. E. Rosenfeld, "The good smooth muscle cells in atherosclerosis," Current Atherosclerosis Reports, vol. 2, no. 5, pp. 422-429, 2000.
34. L. S. Shankman, D. Gomez, O. A. Cherepanova et al., "KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis," Nature Medicine, vol. 21, no. 6, pp. 628-637, 2015.
35. A. C. Doran, N. Meller, and C. A. McNamara, "Role of smooth muscle cells in the initiation and early progression of atherosclerosis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 812-819, 2008.
36. F. E. Rey, "The reactive adventitia: fibroblast oxidase in vascular function," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 12, pp. 1962-1971, 2002.
37. C. J. Schwartz and J. R. Mitchell, "Cellular infiltration of the human arterial adventitia associated with atheromatous plaques," Circulation, vol. 26, no. 1, pp. 73-78, 1962.
38. Y. Shi, J. E. O'Brien, A. Fard, and A. Zalewski, "Transforming growth factor-beta 1 expression and myofibroblast formation during arterial repair," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 10, pp. 1298-1305, 1996.
39. M. Fujiwara, Y. Muragaki, and A. Ooshima, "Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity," Archives of Dermatological Research, vol. 297, no. 4, pp. 161-169, 2005.
40. A. Jabs, E. I. Okamoto, J. Vinten-Johansen, G. Bauriedel, and J. N. Wilcox, "Sequential patterns of chemokine-and chemokine receptor-synthesis following vessel wall injury in porcine coronary arteries," Atherosclerosis, vol. 192, no. 1, pp. 75-84, 2007.
41. F. Xu, J. Ji, L. Li, R. Chen, and W. C. Hu, "Adventitial fibroblasts are activated in the early stages of atherosclerosis in the apolipoprotein E knockout mouse," Biochemical and Biophysical Research Communications, vol. 352, no. 3, pp. 681-688, 2007.
42. M. J. Haurani and P. J. Pagano, "Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease?" Cardiovascular Research, vol. 75, no. 4, pp. 679-689, 2007.
43. J. Liu, A. Ormsby, N. Oja-Tebbe, and P. Pagano, "Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy," Circulation Research, vol. 95, no. 6, pp. 587-594, 2004.
44. F. Xu, Y. Liu, L. Shi et al., "NADPH oxidase p47phox siRNA attenuates adventitial fibroblasts proliferation and migration in apoE(-/-) mouse," Journal of Translational Medicine, vol. 13, no. 1, p. 38, 2015.
45. M. J. Mulligan-Kehoe and M. Simons, "Vasa vasorum in normal and diseased arteries," Circulation, vol. 129, no. 24, pp. 2557-2566, 2014.
46. C. L. Hu, J. Z. Xiang, and F. F. Hu, "Vanilloid receptor TRPV1, sensory C-fibers, and activation of adventitial mast cells. A novel mechanism involved in adventitial inflammation," Medical Hypotheses, vol. 71, no. 1, pp. 102-103, 2008.
47. M. P. Moos, N. John, R. Gräbner et al., "The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 11, pp. 2386-2391, 2005.
48. H. Ait-Oufella, A. P. Sage, Z. Mallat, and A. Tedgui, "Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis," Circulation Research, vol. 114, no. 10, pp. 1640-1660, 2014.
49. C. Y. Miao and Z. Y. Li, "The role of perivascular adipose tissue in vascular smooth muscle cell growth," British Journal of Pharmacology, vol. 165, no. 3, pp. 643-658, 2012.
50. M. Takaoka, H. Suzuki, S. Shioda et al., "Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 8, pp. 1576-1582, 2010.
51. M. R. Schroeter, N. Eschholz, S. Herzberg et al., "Leptindependent and leptin-independent paracrine effects of perivascular adipose tissue on neointima formation," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 5, pp. 980-987, 2013.
52. A. Salgado-Somoza, E. Teijeira-Fernández, Á. L. Fernández, J. R. González-Juanatey, and S. Eiras, "Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress," American Journal of Physiology. Heart and Circulatory Physiology, vol. 299, no. 1, pp. H202-H209, 2010.
53. N. Maenhaut and J. Van de Voorde, "Regulation of vascular tone by adipocytes," BMC Medicine, vol. 9, no. 1, p. 25, 2011.
54. D. Lamers, R. Schlich, S. Greulich, S. Sasson, H. Sell, and J. Eckel, "Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells," Journal of Cellular and Molecular Medicine, vol. 15, no. 5, pp. 1177-1188, 2011.
55. M. K. Öhman, W. Luo, H. Wang et al., "Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice," Atherosclerosis, vol. 219, no. 1, pp. 33-39, 2011.
56. R. M. Lee, C. Lu, L. Y. Su, and Y. J. Gao, "Endothelium-dependent relaxation factor released by perivascular adipose tissue," Journal of Hypertension, vol. 27, no. 4, pp. 782-790, 2009.
57. T. P. Fitzgibbons, S. Kogan, M. Aouadi, G. M. Hendricks, J. Straubhaar, and M. P. Czech, "Similarity of mouse perivascular and brown adipose tissues and their resistance to dietinduced inflammation," American Journal of Physiology. Heart and Circulatory Physiology, vol. 301, no. 4, pp. H1425-H1437, 2011.
58. L. Chang, L. Villacorta, R. Li et al., "Loss of perivascular adipose tissue on peroxisome proliferator-activated receptorgamma deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis," Circulation, vol. 126, no. 9, pp. 1067-1078, 2012.